|
業務類別
|
Biotechnology |
|
業務概覽
|
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon. |
| 公司地址
| 22722 29th Drive SE, Suite 1000, Bothell, WA, USA, 98021 |
| 電話號碼
| +1 604 210-2217 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.achievelifesciences.com |
| 員工數量
| 25 |
| Mr. Richard Alistair Balfour Stewart |
Chief Executive Officer and Director |
美元 509.88K |
28/04/2025 |
| Mr. Mark K. Oki |
Chief Financial Officer |
美元 30.86K |
28/04/2025 |
| Ms. Jaime Xinos |
Chief Commercial Officer |
-- |
28/04/2025 |
| Mr. Jerry Wan |
Principal Accounting Officer and Vice President, Finance |
-- |
11/03/2025 |
|
|
| Ms. Kristen B. Slaoui, PhD |
Director |
10/01/2025 |
| Ms. Nancy R. Phelan |
Director |
10/01/2025 |
| Mr. Richard Alistair Balfour Stewart |
Chief Executive Officer and Director |
28/04/2025 |
| Mr. Stuart M. Duty |
Independent Director |
28/04/2025 |
| Mr. Thomas Braxton King |
Interim Executive Chairman of the Board |
28/04/2025 |
| Dr. Bridget A. Martell, M.D. |
Independent Director |
28/04/2025 |
| Mr. Thomas Sellig |
Independent Director |
28/04/2025 |
| Dr. Kristin Slaoui, PhD |
Independent Director |
28/04/2025 |
|
|
|
|
